High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer

Neoplasia

Volumn 6, Issue 5, 2004, Pages 432-439

  Mahlamäki, Eija H ^a   Kauraniemi, Päivikki ^a   Monni, Outi ^b   Wolf, Maija ^c   Hautaniemi, Sampsa ^a   Kallioniemi, Anne ^a,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Amplification; cDNA microarray; CGH microarray; Overexpression; Pancreatic cancer

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P21;

AMPLICON; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENE TARGETING; GENETIC IDENTIFICATION; GENOME; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR WEIGHT; MUTATION; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 6944222706     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04130     Document Type: Article

References (48)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, and Thun MJ (2003). Cancer statistics. CA Cancer J Clin 53, 5-26.
2. Greenlee RT, Hill-Harmon MB, Murray T, and Thun MJ (2001). Cancer statistics. CA Cancer J Clin 51, 15-36.
3. Schnall SF and Macdonald JS (1996). Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol 23, 220-228.
4. Lowenfels AB and Maisonneuve P (1999). Pancreatico-biliary malignancy: prevalence and risk factors. Ann Oncol 10, 1-3.
5. Schuller HM (2002). Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2, 455-463.
6. Malka D, Hammel P, Maire F, Rufat P, Madeira I, Pessione F, Levy P, and Ruszniewski P (2002). Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51, 849-852.
7. Schenk M, Schwartz AG, O'Neal E, Kinnard M, Greenson JK, Fryzek JP, Ying GS, and Garabrant DH (2001). Familial risk of pancreatic cancer. J Natl Cancer Inst 93, 640-644.
8. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, and Hruban RH (2001). Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 7, 738-744.
9. Bardeesy N and De Pinho RA (2002). Pancreatic cancer biology and genetics. Nat Rev Cancer 2, 897-909.
10. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, and Kern SE (1997). Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57, 1731-1734.
11. Luttges J, Reinecke-Luthge A, Mollmann B, Menke MA, Clemens A, Klimpfinger M, Sipos B, and Kloppel G (1999). Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch 435, 461-468.
12. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, daCosta LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, and Kern SE (1996). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353.
13. Schleger C, Verbeke C, Hildenbrand R, Zentgraf H, and Bleyl U (2002). c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance. Mod Pathol 15, 462-469.
14. Tobita K, Kijima H, Dowaki S, Kashiwagi H, Ohtani Y, Oida Y, Makuuchi H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, and Makuuchi H (2003). Epidermal growth factor receptor expression in human pancreatic cancer: significance for liver metastasis. Int J Mol Med 11, 305-309.
15. Solinas-Toldo S, Wallrapp C, Muller-Pillasch F, Bentz M, Gress T, and Lichter P. (1996). Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56, 3803-3807.
16. Mahlamäki EH, Höglund M, Gorunova L, Karhu R, Dawiskiba S, Andrėn-Sandberg A, Kallioniemi OP, and Johansson B (1997). Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 20, 383-391.
17. Schleger C, Arens N, Zentgraf H, Bleyl U, and Verbeke C (2000). Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). J Pathol 191, 27-32.
18. Shiraishi K, Okita K, Kusano N, Harada T, Kondoh S, Okita S, Ryozawa S, Ohmura R, Noguchi T, Iida Y, Akiyama T, Oga A, Fukumoto Y, Furuya T, Kawauchi S, and Sasaki K (2001). A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas. Oncology 60, 151-161.
19. Harada T, Okita K, Shiraishi K, Kusano N, Kondoh S, and Sasaki K (2002). Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. Cancer Res 62, 835-839.
20. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, Jones M, Tyson K, Bassi C, Scarpa A, and Lemoine NR (2001). Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 20, 7437-7446.
21. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B, Stamp G, Baron A, Scarpa A, and Lemoine NR (2002). Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21, 4587-4594.
22. Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, and Von Hoff DD (2002). Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 62, 2890-2896.
23. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, and Hruban RH (2002). Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 160, 1239-1249.
24. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, Van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, and Goggins M (2003). Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 162, 1151-1162.
25. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, and Hanash S (2003). Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63, 2649-2657.
26. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, and Trent JM (1996). Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14, 457-460.
27. Mousses S, Bittner ML, Chen Y, Dougherty ER, Baxevanis A, Meltzer PS, and Trent JM (2000). Gene expression analysis by cDNA microarrays. In Livesey, FJ, Hunt, SP (Eds.), Functional Genomics, pp. 113-137 Oxford University Press, Oxford.
28. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, and Brown PO (1999). Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23, 41-46.
29. Monni O, Bärlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, Paavola P, Avela K, Chen Y, Bittner ML, and Kallioniemi A (2001). Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA 98, 5711-5716.
30. Chen Y, Dougherty ER, and Bittner ML (1997). Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Opt 2, 364-374.
31. Yang Y, Dudoit S, Luu P, and Speed T (2001). Normalization for cDNA microarray data. In Bittner M, Chen Y, Dorsel A, Dougherty E (Eds.), Microarrays: Optical Technologies and Informatics SPIE, pp. 141-152 Society for Optical Engineering, San Jose.
32. Cleveland W (1979). Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74, 829-836.
33. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringnér M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, and Kallioniemi A (2002). Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62, 6240-6245.
34. Hautaniemi S, Ringner M, Kauraniemi P, Autio R, Edgren H, Yli-Harja O, Astola J, Kallioniemi A, and Kallioniemi OP (2004). A strategy for identifying putative causes of gene expression variation in human cancers. J Franklin Inst 341, 77-88.
35. Fernandez E, La Vecchia C, Porta M, Negri E, Lucchini F, and Levi F (1994). Trends in pancreatic cancer mortality in Europe, 1955-1989. Int J Cancer 57, 786-792.
36. Höglund M, Gorunova L, Andrén-Sandberg A, Dawiskiba S, Mitelman F, and Johansson B (1998). Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: frequent loss of 19p13.3 and gain of 19q13.1-13.2. Genes Chromosomes Cancer 21, 8-16.
37. Mahlamäki EH, Bärlund M, Tanner M, Gorunova L, Höglund M, Karhu R, and Kallioniemi A (2002). Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 35, 353-358.
38. Jansen RP, Hurt EC, Kern H, Lehtonen H, Carmo-Fonseca M, Lapeyre B, and Tollervey D (1991). Evolutionary conservation of the human nucleolar protein fibrillarin and its functional expression in yeast. J Cell Biol 113, 715-729.
39. Stachora AA, Schafer RE, Pohlmeier M, Maier G, and Ponstingl H (1997). Human Supt5h protein, a putative modulator of chromatin structure, is reversibly phosphorylated in mitosis. FEBS Lett 409, 74-78.
40. Sen S, Zhou H, and White RA (1997). A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14, 2195-2200.
41. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ, and Plowman GD (1998). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17, 3052-3065.
42. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, and Sen S (1998). Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20, 189-193.
43. Nigg EA (2001). Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2, 21-32.
44. Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA, and Sen S (2004). Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 36, 55-62.
45. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, and Brown PO (2002). Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99, 12963-12968.
46. Qu J, Cammarano MS, Shi Q, Ha KC, de Lanerolle P, and Minden A (2001). Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol Cell Biol 21, 3523-3533.
47. Callow MG, Clairvoyant F, Zhu S, Schryver B, Whyte DB, Bischoff JR, Jallal B, and Smeal T (2002). Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem 277, 550-558.
48. Zhang H, Li Z, Viklund EK, and Stromblad S (2002). p21-activated kinase 4 interacts with integrin alpha v beta 5 and regulates alpha v beta 5-mediated cell migration. J Cell Biol 158, 1287-1297.